Literature DB >> 15259060

Gastric malignancies in Northern Jordan with special emphasis on descriptive epidemiology.

Kamal-E Bani-Hani1, Rami-J Yaghan, Hussein-A Heis, Nawaf-J Shatnawi, Ismail-I Matalka, Amjad-M Bani-Hani, Kamal-A Gharaibeh.   

Abstract

AIM: To study the epidemiology of gastric malignancies in Jordan as a model for Middle East countries where such data is scarce.
METHODS: Pertinent epidemiological and clinicopathological data for 201 patients with gastric malignancy in north of Jordan between 1991 and 2001 were analyzed.
RESULTS: Male: female ratio was 1.8:1. The mean age was 61.2 years, and 8.5% of the patients were younger than 40 years of age. The overall age-adjusted incidence was 5.82/100 000 population/year. The age specific incidence for males raised from 1.48 in those aged 30-39 years to 72.4 in those aged 70-79 years. Adenocarcinomas, gastric lymphomas, malignant stromal tumors, and carcinoids were found in 87.5%, 8%, 2.5%, and 2% respectively. There was an average of 10.1-month delay between the initial symptoms and the diagnosis. Only 82 patients underwent curative gastrectomy. Among adenocarcinoma groups, Lauren intestinal type was the commonest (72.2%) and the distal third was the most common localization (48.9%). The mean follow up for patients with gastric adenocarcinoma was 25.1 mo (range 1-132 mo). The 5-year survival rates for stages I (n=15), II (n=41), III (n=59), and IV (n=53) were 67.3%, 41.3%, 5.7%, and 0% respectively (P=0.0001). The overall 5 year survival was 21.1%.
CONCLUSION: Despite low incidence, some epidemiological features of gastric cancer in Jordan mimic those of high-risk areas. Patients are detected and treated after a relatively long delay. No justification in favor of a possible gastric cancer screening effort in Jordan is supported by our study; rather, the need of an earlier diagnosis and subsequent better care.

Entities:  

Mesh:

Year:  2004        PMID: 15259060      PMCID: PMC4724987          DOI: 10.3748/wjg.v10.i15.2174

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

Review 1.  The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions?

Authors:  P A Davis; T Sano
Journal:  Crit Rev Oncol Hematol       Date:  2001-10       Impact factor: 6.312

Review 2.  An interpretive review of lymphoma of the stomach.

Authors:  N R Hertzer; S O Hoerr
Journal:  Surg Gynecol Obstet       Date:  1976-07

3.  Gastric carcinoma at Tikur Anbessa Hospital, Addis Ababa.

Authors:  O Johnson; T Ersumo; A Ali
Journal:  East Afr Med J       Date:  2000-01

4.  Primary gastrointestinal lymphomas in Jordan are similar to those in Western countries.

Authors:  N M Almasri; M al-Abbadi; E Rewaily; A Abulkhail; M S Tarawneh
Journal:  Mod Pathol       Date:  1997-02       Impact factor: 7.842

5.  The mixed type in Laurén's classification of gastric carcinoma. Histologic description and biologic behavior.

Authors:  S Stelzner; P Emmrich
Journal:  Gen Diagn Pathol       Date:  1997-07

6.  [Incidence of gastric cancer in the 02 health area of Castellon].

Authors:  R Monferrer Guardiola; A M Peiro Gomez; R Galiana Gil; A Montes Rotgla; A Lillo Sanchez; A Cuevas Campos
Journal:  An Med Interna       Date:  1996-02

7.  Clinical implications of recent developments in gastric cancer pathology and epidemiology.

Authors:  P Correa
Journal:  Semin Oncol       Date:  1985-03       Impact factor: 4.929

8.  Gastric carcinoma in the Kenyan African population.

Authors:  E O Ogutu; G N Lule; F Okoth; A O Musewe
Journal:  East Afr Med J       Date:  1991-05

9.  Reproducibility of histologic classification of gastric cancer.

Authors:  D Palli; S Bianchi; F Cipriani; P Duca; A Amorosi; C Avellini; A Russo; A Saragoni; P Todde; E Valdes
Journal:  Br J Cancer       Date:  1991-05       Impact factor: 7.640

10.  Dietary factors and stomach cancer mortality.

Authors:  L T Ngoan; T Mizoue; Y Fujino; N Tokui; T Yoshimura
Journal:  Br J Cancer       Date:  2002-07-01       Impact factor: 7.640

View more
  8 in total

1.  Effect of p27(KIP1) on cell cycle and apoptosis in gastric cancer cells.

Authors:  Jian-Yong Zheng; Wei-Zhong Wang; Kai-Zong Li; Wen-Xian Guan; Wei Yan
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  Outcome as a measure of quality of care in oncology: experience at sultan qaboos university hospital, oman.

Authors:  Ikram A Burney; Mansour S Al Moundhri; Azhar J Rizvi; Shyam S Ganguly; Rashid Al Abri; Rafi A Ashrafi
Journal:  Sultan Qaboos Univ Med J       Date:  2008-03

3.  Advanced gastric cancer in jordan from 2004 to 2008: a study of epidemiology and outcomes.

Authors:  Salah Y Abbasi; Hani El Taani; Adnan Saad; Ahmed Badheeb; Ala' Addasi
Journal:  Gastrointest Cancer Res       Date:  2011-07

4.  Clinicopathological comparison between young and old age patients with gastric adenocarcinoma.

Authors:  Kamal E Bani-Hani
Journal:  Int J Gastrointest Cancer       Date:  2005

5.  Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.

Authors:  Sajjad Karim; Arif Ali
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

6.  Apoptosis induced by preoperative oral 5'-DFUR administration in gastric adenocarcinoma and its mechanism of action.

Authors:  Wen-He Zhao; Shi-Fu Wang; Wei Ding; Jian-Ming Sheng; Zhi-Min Ma; Li-Song Teng; Min Wang; Fu-Sheng Wu; Bing Luo
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

7.  Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race.

Authors:  Mitchell S Wachtel; Yan Zhang; Maurizio Chiriva-Internati; Eldo E Frezza
Journal:  BMC Cancer       Date:  2006-03-15       Impact factor: 4.430

8.  Epidemiologic characteristics of gastric malignancies among Jordan University Hospital patients.

Authors:  Heyam A Awad; Manar H Hajeer; Mohand W Abulihya; Mohammad A Al-Chalabi; Ali A Al Khader
Journal:  Saudi Med J       Date:  2017-09       Impact factor: 1.484

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.